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INTRODUCTION
Although osteoporosis is more generally considered as a dis-
ease that afflicts women, it is also prevalent in men. The inci-
dence of osteoporotic fractures in men is about half of that in
women (1). Furthermore, the mortality associated with hip
fracture in elderly men is considerably higher than in women
(2). However, the cellular and molecular basis underlying male
osteoporosis is still poorly understood due to the emphasis
on osteoporosis in women (3).
Peak bone mass, which is recognized as an important deter-
minant in development of osteoporosis (4), is under strong
genetic control, and genetic influences have been estimated
to account for about 75% of the inter-individual variability
in peak bone mass (5). Although many genes have been exam-
ined for their association with bone mass, most studies were
carried out in either women or populations of older subjects
of an age when accretion of bone mass has ceased and bone
loss has begun (6). Genetic studies in men with peak bone
mass are relatively rare (3).
LDL receptor-related protein 5 (LRP5) has emerged as a
key regulator of osteoblast proliferation and bone formation
(7, 8). Loss-of-function mutations of the LRP5 gene cause
the autosomal recessive osteoporosis pseudoglioma syndrome
(OPPG), a disorder causing both congenital osteoporosis and
eye abnormalities (7), while autosomal dominant high bone
mass (HBM) traits result from a gain-of-function mutation
of the gene that causes a glycine-to-valine amino acid change
(G171V) (9-11). Collectively, these studies suggest that the
LRP5 gene is an important regulator of peak bone mass in
vertebrates, although genetic mutations causing OPPG syn-
drome or HBM phenotype are very rare in the general pop-
ulation (7, 11).
It has been suggested that a common polymorphism in the
LRP5 gene might contribute to genetic variations in bone
mass in the general community (12). Torus palatinus, which
was observed in subjects with the G171V mutation of the
LRP5 gene, is commonly detected in the general population
(13, 14), and this was reported to serve as a physical marker
of high bone mineral density (BMD) in Caucasians (13) and
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Association between Bone Mineral Density and LDL Receptor-Related
Protein 5 Gene Polymorphisms in Young Korean Men
Recently, It has been reported that the LDL receptor-related protein 5 (LRP5) reg-
ulates bone formation, and that mutations of the gene cause osteoporosis-pseudo-
glioma syndrome or high bone mass phenotypes. However, the mutations cannot
explain a genetic trait for osteoporosis in the general population because of their
rarity. From 219 Korean men aged 20-34 yr, we looked for six known polymorphisms
causing amino acid changes in the LRP5 coding region, and investigated their asso-
ciation with bone mineral density (BMD) at the following anatomical sites: lumbar
spine (L2-L4) and the left proximal femur (femoral neck, Ward’s triangle, trochanter
and shaft). We found that the Q89R polymorphism was significantly associated with
BMD at the femoral neck and Ward’s triangle (p=0.004 and <0.001, respectively).
However, after adjusting for age, weight and height, a statistically significant associa-
tion only occurred at the Ward’s triangle (p=0.043), and a marginal association was
observed at the femoral neck (p=0.098). No A400V, V667M, R1036Q and A1525V
polymorphisms were found, and no statistically significant association was found
between the A1330V polymorphism and BMD at any sites. Although we failed to
demonstrate a clear association between the LRP5 polymorphism and peak bone
mass in young men, the present study suggests that larger-scale studies on the
Q89R polymorphism need to be performed. 
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Japanese (15). More importantly, several quantitative trait
locus (QTL) analyses reported that the region 11q12-13, which
contains the LRP5 gene, strongly contributes to the normal
variation of BMD in the general population (16, 17). How-
ever, there is no information on whether LRP5 polymorphisms
are associated with BMD in the general community.
Recently, two mutation analyses reported seven and forty-
two LRP5 gene polymorphisms in Japanese (18) and Cau-
casians (19), respectively. In the present study, we examined
LRP5 gene coding region polymorphisms in young Korean
men. We determined the frequency of occurrence of six poly-
morphisms causing amino acid changes, and investigated
whether these polymorphisms were associated with BMD.
MATERIALS AND METHODS
Subjects 
The study population comprised 219 healthy young men
who were medical students of University of Ulsan or residents
at a university hospital (Asan Medical Center (AMC)) in Seoul,
Korea. All subjects were Korean and volunteered for the study.
The study was approved by the AMC ethics review commit-
tee and written informed consent was obtained from all sub-
jects. Subjects completed a self-administered questionnaire
concerning demographic characteristics, general health status,
medication, weekly duration of weight-bearing physical activ-
ity, and smoking and alcohol drinking habits. Daily dietary
calcium intake was assessed using a food frequency question-
naire (20, 21). All subjects were free from drugs and diseases
known to affect bone metabolism.
Bone mineral densitometry
All BMD (g/cm2) measurements of the lumbar spine (L2-
L4, A-P) and the left proximal femur (femoral neck, Ward’s
triangle, trochanter and shaft) were measured by the same
trained technician using a Lunar Corp. Expert XL (Lunar,
Madison, WI, U.S.A.) dual energy radiography absorptiome-
ter (software version 1.90). The in vivo precision of the machine
was 0.82% for the lumbar spine, 1.12% for the femoral neck
and 2.17% for Ward’s triangle.
Genotype analysis with polymerase chain reaction and
restriction fragment length polymorphism analysis
Genomic DNA was extracted from peripheral blood leuko-
cytes using a commercial kit (Wizard Genomic DNA purifi-
cation kit, Promega, Madison, WI, U.S.A.). Genotyping of
DNA sequence variants in the Q89R and A1330V sites was
carried out by restriction enzyme analysis of polymerase chain
reaction (PCR)-amplified DNA using specific pairs of oligonu-
cleotide primers, as described previously (18). The PCR pri-
mers were sequence-specific and/or mutated for convenience.
Amplification of polymorphisms was carried out using a ther-
mocycler (Perkin-Elmer, Boston, MA, U.S.A.) using a method
described previously with some modifications (18). After am-
plification, PCR products were digested with restriction en-
donucleases AvaII and DraIII (New England Biolabs Inc.,
Beverly, MA, U.S.A.) for the Q89R and A1330V polymor-
phisms, respectively. The DNA fragments were then elec-
trophoresed on 2% and 3% agarose gels for the Q89R and
A1330V polymorphisms, respectively.
Because previously reported restriction enzyme analyses of
polymerase chain reaction (PCR) were not available, genotyp-
ing for A400V, V667M, R1036Q and A1525V polymorphi-
sms was performed by SNP-ITTM assays using the SNP stream
25KTM System (Orchid Biosciences, New Jersey, U.S.A.) (22).
Briefly, the genomic DNA region spanning the polymorphic
site was PCR-amplified using one phosphothiolated primer
and one regular PCR primer. The amplified PCR products
were then digested with exonuclease, with the 5′ phosphoth-
iolates protecting one strand of the PCR product from diges-
tion. The single-strand PCR template generated by exonucle-
ase digestion was overlaid onto a 384-well plate that was pre-
coated covalently with the primer extension SNP-ITTM pri-
mers. These SNP-ITTM primers were designed to hybridize
immediately adjacent to the polymorphic site. The PCR pri-









V667M Forward 5′ -AGAGCCGCCATCCACAGG-3′
Reverse 5′ -ATCAAAGTCCAGGGCTGAG-3′
SNP-IT
TM  5′ -CTCCCTCGAGACCAATAACAAC-
GAC-3′











A400V Forward 5′ -CCTGGCTGAGTATTTCC-3′
Reverse 5′ -TCAATCTCCCTCTCGCC-3′
V667M Forward 5′ -CTGTGCACATTGGAGCT-3′
Reverse 5′ -CAAGGTTTTCCCATAAAGG-3′
R1036Q Forward 5′ -TGGGATTTGACTTTCAGG-3′
Reverse 5′ -CCTGTGAGAGGCTGGCA-3′
A1525V Forward 5′ -AACATGCAGTGCCCGCT-3′
Reverse 5′ -CTTCGGGGCAGGTGGCT-3′
Table 1. Primer sequences for SNP-IT
TM assays and for direct
sequencing within the LDL receptor-related protein 5 gene template strands, SNP-ITTM primers were then extended by
a single base with DNA polymerase at the polymorphic site
of interest. The extension mixtures contained two labeled
terminating nucleotides (one FITC, one biotin) and two unla-
beled terminating nucleotides. The final single base incorpo-
rated was identified with serial colorimetric reactions with
anti-FITC-AP or streptavidin-HRP. The results of blue and/or
yellow color developments were analyzed using an ELISA
reader, and the final genotyping (allele) calls were made using
the QCReviewTM program. To confirm polymorphisms iden-
tified using SNP-ITTM assays, direct DNA sequencing was
performed on 20 samples using a fluorescence-based automat-
ed DNA sequencer, as previously described (19). The PCR
primer sequences used for direct sequencing are listed in Table
1. The PCR products were directly sequenced on both strands
using an ABI Prism 377 DNA sequencer (Perkin Elmer, CA,
U.S.A.). No discrepancies were found between direct sequenc-
ing data and SNP-ITTM data (data not shown).
Statistical analysis
Descriptive characteristics are expressed as mean and stan-
dard deviation. The independent contribution of the clinical
characteristics to BMD was determined using multiple linear
regression analysis. Linkage disequilibrium between genotypes
and significance of deviation from the Hardy-Weinberg equi-
librium were analyzed by the  2 test. Haplotypes were con-
structed using the E-M algorithm (Arlequin, http://anthro.
unige.ch/arlequin/). The effect of single or combined geno-
types on BMD was evaluated using either unpaired t-tests or
one-way analyses of variance. Multiple linear regression analy-
ses were performed to adjust for risk factors, with BMD as a
dependent variable, and genotypes, age, weight and height
each being independent variables. Unless indicated otherwise,
p values less than 0.05 were considered significant. The SPSS




The mean age of participants was 25.6±3.7 yr (range 20-
34 yr). Body mass index was 22.9±2.8 kg/m2 (range 17.2-
32.1 kg/m2). Multiple linear regression analysis showed a posi-
tive association between body weight and BMD at all anatom-
ical sites: =0.275,  p=0.001 at the lumbar spine;  =0.253,
p=0.001 at the femoral neck;  =0.216, p=0.004 at the Ward’s
triangle; =0.329,  p<0.001 at the trochanter;  =0.299, p<
0.001 at the femoral shaft. Age was negatively correlated with
BMD at the proximal femur, with regression analysis show-
ing =-0.312,  p<0.001 at the femoral neck;  =-0.349, p<
0.001 at the Ward’s triangle;  =-0.192, p=0.010 at the tro-
chanter; and  =-0.223, p=0.003 at the femoral shaft. There
was no association between BMD and height, calcium intake,
smoking, alcohol consumption or exercise (data not shown).
Genotype frequencies
The genotype distributions and allele frequencies for LRP5
gene polymorphisms are presented in Table 2. No polymor-
phisms of the A400V, V667M, R1036Q or A1525V type
were observed. These data differ from those obtained from
Caucasian subjects (19). We detected Q89R and A1330V
polymorphisms, and these occurred at allelic frequencies com-
parable to those previously reported in Japanese studies (18).
The Q89R and A1330V polymorphisms were in Hardy-Wein-
berg equilibrium. Because the number of subjects bearing
the VV genotype of the A1330V polymorphism was so small
(n=7), we compared those carrying the V allele (AV or VV)
with those that did not (AA). Contradictory to the previous
result suggesting that the two polymorphisms were in another
linkage disequilibrium blocks in European (23), the distribu-
tion of combination genotypes indicated that the two poly-
morphisms were in linkage disequilibrium in our subjects
( 2=19.526, p<0.001). The haplotype frequencies were: QA,
357 (81.5%); QV, 44 (10.0%); RA, 16 (3.7%); RV, 21 (4.8%).
Combined genotypes were constructed from the haplotypes
and their frequencies were: QA-QA, 145 (66.2%); QA-QV,
32 (14.6%); QA-RA, 16 (7.3%); QA-RV, 19 (8.7%); QV-
QV, 5 (2.3%); QV-RV, 2 (0.9%).
Association between LRP5 gene polymorphisms and BMD
The study population data were separated into two cate-
gories on the basis of Q89R or A1330V polymorphisms in
the LRP5 gene. No significant differences in any clinical para-
meters were observed between the two groups (Table 3). How-
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Sites p value
� Genotype Frequencies* Allele Frequencies
Q89R QQ QR RR Q R
182 (83.1%) 37 (16.9%) 0 (0%) 0.92 0.08 0.394
A400V AA AV VV A V
219 (100%) 0 (0%) 0 (0%) 1 0 -
V667M VV VM MM V M
219 (100%) 0 (0%) 0 (0%) 1 0 -
R1036Q RR RQ QQ R Q
219 (100%) 0 (0%) 0 (0%) 1 0 -
A1330V AA AV VV A V
161 (73.5%) 51 (23.3%) 7 (3.2%) 0.85 0.15 0.508
A1525V AA AV VV A V
219 (100%) 0 (0%) 0 (0%) 1 0 -
Table 2. Genotype distribution and allele frequencies of polymor-
phisms of the LDL receptor-related protein 5 gene
*Values represent number of times the allele was detected (% of all sub-
jects).
� Deviation from the Hardy-Weinberg equilibrium as determined by
2 test. A p value >0.05 indicates the genotypes are in Hardy-Weinberg
equilibrium. 410 J.-M. Koh, M.H. Jung, J.S. Hong, et al.
ever, subjects with the QQ genotype had significantly higher
BMD at the femoral neck and Ward’s triangle, compared with
those with the QR genotype (p=0.004 and p<0.001, respec-
tively). Lumbar BMD was not different between the two
groups. Multiple linear regression analyses were undertaken
in order to adjust confounding variables such as age, weight
and height. The Q89R polymorphism was significantly asso-
ciated with BMD at the Ward’s triangle (p=0.043), and mar-
ginally associated at the femoral neck (p=0.098) (Table 4).
When the study subjects were divided into two groups
according to the presence of the V allele of the A1330V poly-
morphism, those with the V allele (AV or VV genotype) had
lower body weight than those without (AA genotype) (p=
0.035, Table 3). Other clinical parameters were similar be-
tween the two groups (data not shown). No differences in
BMD values at any sites were noted between these two groups
both before (Table 3) and after (Table 4) adjusting for con-
founding variables.
We also examined effects of the combined genotypes on
BMD. The subjects were divided into three groups according
to the number of QA haplotypes: (QA haplotype=2)=(1, 1),
(QA haplotype=1)=(1, 0), and (QA haplotype=0)=(0, 0). No
associations between the combined genotypes and BMD were
noted at any sites before or after adjusting for confounding
variables (data not shown).
DISCUSSION
To our knowledge, this is the first study examining the
association between LRP5 gene polymorphisms and BMD








































Table 4. Multiple linear regression analysis with BMD as the dependent variable, and age, weight, height and genotypes as the inde-
pendent variables
*NS denotes not significant.
QQ (n=182) QR (n=37)
Q89R polymorphism
AA (n=161) AV/VV (n=58)
A1330V polymorphism
Age (yr) 25.4±3.9 25.9±4.8 25.3±3.6 25.8±3.4
Weight (kg) 69.1±8.9 68.9±8.1 69.8±8.5 67.0±9.3
�
Height (cm) 174.3±5.1 172.9±5.4 174.3±5.2 173.6±4.9
BMI (kg/m
2) 22.7±2.6 23.1±2.5 23.0±2.5 22.2±2.8
Calcium intake (mg/day) 590±74 595±70 594±75 580±65
Smoking (pack/yr) 2.31±0.87 2.17±0.92 2.35±0.87 2.14±0.90
Alcohol consumption (g/day) 16.7±27.2 16.1±15.2 17.0±26.6 15.5±22.9
Exercise (hr/day) 1.5±1.5 1.5±1.8 1.5±1.6 1.4±1.5
BMD (g/cm
2)
Lumbar spine 1.200±0.175 1.202±0.119 1.198±0.179 1.206±0.125
Femoral neck 1.069±0.160 1.006±0.108* 1.067±0.154 1.032±0.154
Ward’ triangle 1.002±0.179 0.918±0.109
� 0.999±0.173 0.956±0.164
Trochanter 0.853±0.181 0.811±0.131 0.849±0.173 0.837±0.178
Femoral shaft 1.354±0.177 1.312±0.132 1.358±0.174 1.316±0.160
Table 3. Comparison of clinical characteristics and BMD (g/cm
2). The study population was separated into two groups on the basis
of having either the Q89R or A1330V polymorphism in the LDL receptor-related protein 5 gene
All values are mean±SD. Differences in clinical characteristics between the two groups were tested using unpaired t-tests, where: *p<0.005 vs. QQ;
�
p<0.001 vs. QQ; 
�
p<0.05 vs. AA.icant association between the Q89R polymorphism and BMD
at Ward’s triangle after adjusting for confounding variables.
This association may have to be viewed with circumspection.
The precision error for Ward’s triangle measurement is con-
siderably higher than for other regions of interest (24, 25).
Further, the association was not noted at the lumbar spine,
which has similar compositions of cortical and trabecular bone
to the Ward’s triangle. These suggest that the significant asso-
ciation may result from false positive one. However, the asso-
ciation was suggested at the femoral neck, albeit marginal
(p=0.098). Therefore, we cannot exclude a possibility that this
somewhat weak association is due to the small sample size
providing insufficient statistical power to show modest but
statistically significant associations.
The association of the Q89R polymorphism with BMD
appears to be further supported by the position at which this
polymorphism is situated in the LRP5 gene. The LRP5 gene
contains 23 exons and spans >100 kb (26). The LRP5 protein
consists of a distinct ensemble of five structural motifs-four
structures resembling a propeller with six blades containing
YWTD spacer repeat domains, epidermal growth factor-like
repeats, an LDL receptor-like ligand-binding domain, a sin-
gle transmembrane domain, and a short cytoplasmic tail (27,
28). The Q89R polymorphism is located in exon 2 encoding
the first of four propellers, while the A1330V polymorphism
is in exon 18 encoding the LDL receptor-like domain. Alth-
ough the precise function of each region is uncertain, the four
propellers are of structural importance. It has been suggested
that mutation in the first propeller region can alter the local
hydrophobic environment, thus possibly affecting the inter-
action of LRP5 with other proteins (11). In addition, a num-
ber of mutations in this region in the LDL receptor propeller
module can cause familial hypercholesterolemia (28), confirm-
ing that this domain is important for protein function. These
suggest a possibility that the Q89R or related linked poly-
morphisms coding the region might alter LRP5 protein func-
tion and might be associated with BMD, suggesting need for
further studies on functional differences of these polymor-
phisms in relation to bone metabolism.
In the present study we observed different genetic back-
grounds between Koreans and Caucasians with respect to
allele frequencies of LRP5 gene polymorphisms. The allele
frequencies of the A400V, V667M, R1036Q and A1525V
polymorphisms in Caucasians were 2-8% (19), whereas no
such polymorphisms were found in our subjects. More impor-
tantly, the Q89R polymorphism was very rare in Caucasians
(19, 29), whereas the polymorphism was prevalent in Japanese
(18) and our Korean subjects. These data suggest that the
Q89R polymorphism would not be a useful marker for bone
mass in Caucasians.
In conclusion, we failed to demonstrate a clear association
between the LRP5 polymorphism and peak bone mass in
young men. However, the present study suggests that larger-
scale studies on the Q89R polymorphism are needed. 
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